Correlation Between Sonoma Pharmaceuticals and Organogenesis Holdings
Can any of the company-specific risk be diversified away by investing in both Sonoma Pharmaceuticals and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonoma Pharmaceuticals and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonoma Pharmaceuticals and Organogenesis Holdings, you can compare the effects of market volatilities on Sonoma Pharmaceuticals and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonoma Pharmaceuticals with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonoma Pharmaceuticals and Organogenesis Holdings.
Diversification Opportunities for Sonoma Pharmaceuticals and Organogenesis Holdings
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Sonoma and Organogenesis is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Sonoma Pharmaceuticals and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and Sonoma Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonoma Pharmaceuticals are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of Sonoma Pharmaceuticals i.e., Sonoma Pharmaceuticals and Organogenesis Holdings go up and down completely randomly.
Pair Corralation between Sonoma Pharmaceuticals and Organogenesis Holdings
Given the investment horizon of 90 days Sonoma Pharmaceuticals is expected to under-perform the Organogenesis Holdings. In addition to that, Sonoma Pharmaceuticals is 1.75 times more volatile than Organogenesis Holdings. It trades about -0.02 of its total potential returns per unit of risk. Organogenesis Holdings is currently generating about 0.04 per unit of volatility. If you would invest 317.00 in Organogenesis Holdings on August 28, 2024 and sell it today you would earn a total of 87.00 from holding Organogenesis Holdings or generate 27.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Sonoma Pharmaceuticals vs. Organogenesis Holdings
Performance |
Timeline |
Sonoma Pharmaceuticals |
Organogenesis Holdings |
Sonoma Pharmaceuticals and Organogenesis Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sonoma Pharmaceuticals and Organogenesis Holdings
The main advantage of trading using opposite Sonoma Pharmaceuticals and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonoma Pharmaceuticals position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.Sonoma Pharmaceuticals vs. China Pharma Holdings | Sonoma Pharmaceuticals vs. Universe Pharmaceuticals | Sonoma Pharmaceuticals vs. Akanda Corp | Sonoma Pharmaceuticals vs. Petros Pharmaceuticals |
Organogenesis Holdings vs. Shuttle Pharmaceuticals | Organogenesis Holdings vs. Lifecore Biomedical | Organogenesis Holdings vs. Redhill Biopharma | Organogenesis Holdings vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |